Default company panoramic image

Boston Mountain Biotech LLC

Our mission is to provide innovative and cost-effective protein purification solutions to biotech firms and researchers globally.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Fayetteville, AR, USA
  • Currency USD
  • Founded November 2011
  • Employees 2
  • Website

Company Summary

Boston Mountain Biotech is a contract research company simplifying protein pharmaceutical production. Our cell lines help protein therapeutic designers transition from idea to patient trials in half the time by eliminating trial and error purification design. To do this, we provide custom E. coli cell lines with a database of tested purification protocols that make clean proteins faster, with fewer losses more cost effectively.


  • Default avatar
    Ricky L Draehn

    Ricky Draehn, MBA and co-founder of Boston Mountain Biotech has served as Chief Executive Officer since the company’s inception. Ricky has over 25 years of experience in the life sciences industry, 15 of which was in mergers and acquisitions and is also an expert in fermentation and yeast productivity. He has extensive experience working with regulatory agencies such as the Food and Drug Administration (FDA). Ricky’s vast experience makes him

  • Default avatar
    Ellen M Brune

    Ellen Brune, PhD, co-founder, and co-inventor of the technology is the company’s Chief Scientific Officer. Ellen holds a PhD in Chemical Engineering from the University of Arkansas and has received over $1M in research grants from the National Science Foundation and the Arkansas Biosciences Institute. In order to further her understanding of business, Ellen has completed the graduate entrepreneurship certificate program in the Walton College of

  • Default avatar
    Steve Mead

    Steve Mead, MBA and Chief Financial Officer, joined BMB in December 2011. Steve comes to BMB with a diverse background having served as a financial management officer in the United States Air Force. Steve has held various posts during his careers but most recently was responsible for the management and execution of nearly a $500 million budget for the largest consumer packaged goods company in North America.

  • Default avatar
    Beverly Graham
    Sales & Marketing

    Beverly has 21+ years in biotech industry, with responsibilities in all facets of small-company operations, sales and marketing, revenue/cost budgeting, and strategic planning. Having served during this time as global liaison to customers world-wide, handling both direct site sales and trade-show management, her extensive contact list throughout the life sciences industry brings enormous visibility to BMB for potential sales and partnerships

  • Default avatar
    Robert Beitle PhD

    Dr. Beitle holds a PhD Chemical Engineering and brings 25 years Bioprocess & Microbiology experience as well as over 15 years of experience in protein separation to BMB. Dr. Beitle possesses intimate knowledge of the project origins as PI on the original state and federal grants providing preliminary data for the proposed SBIR will help BMB quickly advance through the NIH Phase I and Phase II efforts. His numerous contacts in the biochemical en

  • Default avatar
    Kelly Richert
    Investor Relations

    Kelly is the newest member of BMB’s the management team, joining the company in June 2012. Kelly brings over 19 years of experience in finance and banking, five years of which has been spent developing new business strategies. She has been involved with raising funds for various ventures and her diverse background allows her to assist the team in legal, financial aspects of fund raising, and business operations.


  • Default avatar
    Dawn Christoferson
    Default avatar
    Fred Zrenner

Previous Investors

  • Default avatar
    National Science Foundation (CBET) - IP Development Research - $650,00
    Default avatar
    National Science Foundation - I-Corps Program - $50,000
    Default avatar
    Founders - $120,000